Skip to main content
Top
Published in: BMC Neurology 1/2016

Open Access 01-12-2016 | Research article

The nature of genetic susceptibility to multiple sclerosis: constraining the possibilities

Author: Douglas S. Goodin

Published in: BMC Neurology | Issue 1/2016

Login to get access

Abstract

Background

Epidemiological observations regarding certain population-wide parameters (e.g., disease-prevalence, recurrence-risk in relatives, gender predilections, and the distribution of common genetic-variants) place important constraints on the possibilities for the genetic-basis underlying susceptibility to multiple sclerosis (MS).

Methods

Using very broad range-estimates for the different population-wide epidemiological parameters, a mathematical model can help elucidate the nature and the magnitude of these constraints.

Results

For MS no more than 8.5 % of the population can possibly be in the “genetically-susceptible” subset (defined as having a life-time MS-probability at least as high as the overall population average). Indeed, the expected MS-probability for this subset is more than 12 times that for every other person of the population who is not in this subset. Moreover, provided that those genetically susceptible persons (genotypes), who carry the well-established MS susceptibility allele (DRB1*1501), are equally or more likely to get MS than those susceptible persons, who don’t carry this allele, then at least 84 % of MS-cases must come from this “genetically susceptible” subset. Finally, because men, compared to women, are at least as likely (and possibly more likely) to be susceptible, it can be demonstrated that women are more responsive to the environmental factors that are involved in MS-pathogenesis (whatever these are) and, thus, susceptible women are more likely actually to develop MS than susceptible men. Finally, in contrast to genetic susceptibility, more than 70 % of men (and likely also women) must have an environmental experience (including all of the necessary factors), which is sufficient to produce MS in a susceptible individual.

Conclusions

As a result, because of these constraints, it is possible to distinguish two classes of persons, indicating either that MS can be caused by two fundamentally different pathophysiological mechanisms or that the large majority of the population is at no risk of the developing this disease regardless of their environmental experience. Moreover, although environmental-factors would play a critical role in both mechanisms (if both exist), there is no reason to expect that these factors are the same (or even similar) between the two.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hofker MH, Fu J, Wijmenga C. The genome revolution and its role in understanding complex diseases. Biochim Biophys Acta. 2014;1842(10):1889–95.CrossRefPubMed Hofker MH, Fu J, Wijmenga C. The genome revolution and its role in understanding complex diseases. Biochim Biophys Acta. 2014;1842(10):1889–95.CrossRefPubMed
3.
go back to reference Goodin DS. The epidemiology of multiple sclerosis: insights to disease pathogenesis. Handb Clin Neurol. 2014;122:231–66.CrossRefPubMed Goodin DS. The epidemiology of multiple sclerosis: insights to disease pathogenesis. Handb Clin Neurol. 2014;122:231–66.CrossRefPubMed
4.
go back to reference Ramagopalan SV, Anderson C, Sadovnick AD, Ebers GC. Genomewide study of multiple sclerosis. N Engl J Med. 2007;357:2199–200.CrossRefPubMed Ramagopalan SV, Anderson C, Sadovnick AD, Ebers GC. Genomewide study of multiple sclerosis. N Engl J Med. 2007;357:2199–200.CrossRefPubMed
5.
go back to reference De Jager PL, Jia X, Wang J, de Bakker PI, Ottoboni L, Aggarwal NT, Piccio L, Raychaudhuri S, Tran D, Aubin C, et al. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet. 2009;41:776–82.CrossRefPubMedPubMedCentral De Jager PL, Jia X, Wang J, de Bakker PI, Ottoboni L, Aggarwal NT, Piccio L, Raychaudhuri S, Tran D, Aubin C, et al. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet. 2009;41:776–82.CrossRefPubMedPubMedCentral
6.
go back to reference The International Multiple Sclerosis Genetics Consortium and the Wellcome Trust Case Control Consortium 2. Genetic risk and a primary role for cell mediated immune mechanisms in multiple sclerosis. Nature. 2011;476:214–9.CrossRef The International Multiple Sclerosis Genetics Consortium and the Wellcome Trust Case Control Consortium 2. Genetic risk and a primary role for cell mediated immune mechanisms in multiple sclerosis. Nature. 2011;476:214–9.CrossRef
7.
go back to reference International Multiple Sclerosis Genetics Consortium. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet. 2014;45:1353–60. International Multiple Sclerosis Genetics Consortium. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet. 2014;45:1353–60.
8.
go back to reference Dyment DA, Herrera BM, Cader MZ, Willer CJ, Lincoln MR, Sadovnick AD, Risch N, Ebers GC. Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance. Hum Mol Genet. 2005;14:2019–26.CrossRefPubMed Dyment DA, Herrera BM, Cader MZ, Willer CJ, Lincoln MR, Sadovnick AD, Risch N, Ebers GC. Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance. Hum Mol Genet. 2005;14:2019–26.CrossRefPubMed
9.
go back to reference Hafler DA, Compston A, Sawcer S, Lander ES, Daly MJ, De Jager PL, de Baker PI, Gabriel SB, Mirel DB, Ivinson AJ, et al., and International Multiple Sclerosis Genetics Consortium. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med. 2007;357:851–62.CrossRefPubMed Hafler DA, Compston A, Sawcer S, Lander ES, Daly MJ, De Jager PL, de Baker PI, Gabriel SB, Mirel DB, Ivinson AJ, et al., and International Multiple Sclerosis Genetics Consortium. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med. 2007;357:851–62.CrossRefPubMed
10.
go back to reference Witte JS, Carlin JB, Hopper JL. Likelihood-Based Approach to Estimating Twin concordance for dichotomous traits. Genetic Epidemiol. 1999;16:290–304.CrossRef Witte JS, Carlin JB, Hopper JL. Likelihood-Based Approach to Estimating Twin concordance for dichotomous traits. Genetic Epidemiol. 1999;16:290–304.CrossRef
11.
go back to reference Jacobson HI. The maximum variance of restricted unimodal distributions. Ann Math Stat. 1969;40:1746–52.CrossRef Jacobson HI. The maximum variance of restricted unimodal distributions. Ann Math Stat. 1969;40:1746–52.CrossRef
12.
go back to reference Rosati G. The prevalence of multiple sclerosis in the world: an update. Neurol Sci. 2001;22:117–39.CrossRefPubMed Rosati G. The prevalence of multiple sclerosis in the world: an update. Neurol Sci. 2001;22:117–39.CrossRefPubMed
13.
go back to reference Hansen T, Skytthe A, Stenager E, Petersen HC, Kyvik KO, Brønnum-Hansen H. Risk for multiple sclerosis in dizygotic and monozygotic twins. Mult Scler. 2005;11:500–3.CrossRefPubMed Hansen T, Skytthe A, Stenager E, Petersen HC, Kyvik KO, Brønnum-Hansen H. Risk for multiple sclerosis in dizygotic and monozygotic twins. Mult Scler. 2005;11:500–3.CrossRefPubMed
14.
go back to reference Hansen T, Skytthe A, Stenager E, Petersen HC, Brønnum-Hansen H, Kyvik KO. Concordance for multiple sclerosis in Danish twins: an update of a nationwide study. Mult Scler. 2005;11:504–10.CrossRefPubMed Hansen T, Skytthe A, Stenager E, Petersen HC, Brønnum-Hansen H, Kyvik KO. Concordance for multiple sclerosis in Danish twins: an update of a nationwide study. Mult Scler. 2005;11:504–10.CrossRefPubMed
15.
go back to reference O’Gorman C, Lin R, Stankovich J, Broadley SA. Modelling genetic susceptibility to multiple sclerosis with family data. Neuroepidemiology. 2013;40:1–12.CrossRefPubMed O’Gorman C, Lin R, Stankovich J, Broadley SA. Modelling genetic susceptibility to multiple sclerosis with family data. Neuroepidemiology. 2013;40:1–12.CrossRefPubMed
16.
go back to reference Bager P, Nielsen NM, Bihrmann K, Frisch M, Wohlfart J, Koch-Henriksen N, Melbye M, Westergaard T. Sibship characteristics and risk of multiple sclerosis: A nationwide cohort study in Denmark. Am J Epidemiol. 2006;163:1112–7.CrossRefPubMed Bager P, Nielsen NM, Bihrmann K, Frisch M, Wohlfart J, Koch-Henriksen N, Melbye M, Westergaard T. Sibship characteristics and risk of multiple sclerosis: A nationwide cohort study in Denmark. Am J Epidemiol. 2006;163:1112–7.CrossRefPubMed
18.
go back to reference Dyment DA, Yee IML, Ebers GC, Sadovnick AD, the Canadian Collaborative Study Group. Multiple sclerosis in stepsiblings: Recurrence risk and ascertainment. J Neurol Neurosurg Psychiatry. 2006;77:258–9.CrossRefPubMedPubMedCentral Dyment DA, Yee IML, Ebers GC, Sadovnick AD, the Canadian Collaborative Study Group. Multiple sclerosis in stepsiblings: Recurrence risk and ascertainment. J Neurol Neurosurg Psychiatry. 2006;77:258–9.CrossRefPubMedPubMedCentral
19.
go back to reference Ebers GC, Sadovnick AD, Dyment DA, Yee IM, Willer CJ, Risch N. Parent of-origin effect in multiple sclerosis: observations in half-siblings. Lancet. 2004;363:1773–4.CrossRefPubMed Ebers GC, Sadovnick AD, Dyment DA, Yee IM, Willer CJ, Risch N. Parent of-origin effect in multiple sclerosis: observations in half-siblings. Lancet. 2004;363:1773–4.CrossRefPubMed
20.
go back to reference Ebers GC, Yee IML, Sadovnick AD, Duquette P, the Canadian Collaborative Study Group. Conjugal multiple sclerosis: Population based prevalence and recurrence risks in offspring. Ann Neurol. 2000;48:927–31.CrossRefPubMed Ebers GC, Yee IML, Sadovnick AD, Duquette P, the Canadian Collaborative Study Group. Conjugal multiple sclerosis: Population based prevalence and recurrence risks in offspring. Ann Neurol. 2000;48:927–31.CrossRefPubMed
21.
go back to reference Sadovnick AD, Yee IML, Ebers GC, the Canadian Collaborative Study Group. Multiple sclerosis and birth order: A longitudinal cohort study. Lancet Neurol. 2005;4:611–7.CrossRefPubMed Sadovnick AD, Yee IML, Ebers GC, the Canadian Collaborative Study Group. Multiple sclerosis and birth order: A longitudinal cohort study. Lancet Neurol. 2005;4:611–7.CrossRefPubMed
22.
go back to reference Sadovnick AD, Ebers GC, Dyment DA, Risch NJ, the Canadian Collaborative Study Group. Evidence for genetic basis of multiple sclerosis. Lancet. 1996;347:1728–30.CrossRefPubMed Sadovnick AD, Ebers GC, Dyment DA, Risch NJ, the Canadian Collaborative Study Group. Evidence for genetic basis of multiple sclerosis. Lancet. 1996;347:1728–30.CrossRefPubMed
23.
go back to reference Willer CJ, Dyment DA, Rusch NJ, Sadovnick AD, Ebers GC, the Canadian Collaborative Study Group. Twin concordance and sibling recurrence rates in multiple sclerosis. Proc Natl Acad Sci U S A. 2003;100:12877–82.CrossRefPubMedPubMedCentral Willer CJ, Dyment DA, Rusch NJ, Sadovnick AD, Ebers GC, the Canadian Collaborative Study Group. Twin concordance and sibling recurrence rates in multiple sclerosis. Proc Natl Acad Sci U S A. 2003;100:12877–82.CrossRefPubMedPubMedCentral
24.
go back to reference French Research Group on Multiple Sclerosis. Multiple sclerosis in 54 twinships: Concordance rate is independent of zygosity. Ann Neurol. 1992;32:724–7.CrossRef French Research Group on Multiple Sclerosis. Multiple sclerosis in 54 twinships: Concordance rate is independent of zygosity. Ann Neurol. 1992;32:724–7.CrossRef
25.
go back to reference Islam T, Gauderman WJ, Cozen W, Hamilton AS, Burnett ME, Mack TM. Differential twin concordance for multiple sclerosis by latitude of birthplace. Ann Neurol. 2006;60:56–64.CrossRefPubMed Islam T, Gauderman WJ, Cozen W, Hamilton AS, Burnett ME, Mack TM. Differential twin concordance for multiple sclerosis by latitude of birthplace. Ann Neurol. 2006;60:56–64.CrossRefPubMed
26.
go back to reference Mumford CJ, Wood NW, Kellar-Wood H, Thorpe JW, Miller DH, Compston DA. The British Isles survey of multiple sclerosis in twins. Neurology. 1994;44:11–5.CrossRefPubMed Mumford CJ, Wood NW, Kellar-Wood H, Thorpe JW, Miller DH, Compston DA. The British Isles survey of multiple sclerosis in twins. Neurology. 1994;44:11–5.CrossRefPubMed
27.
go back to reference Ristori G, Cannoni S, Stazi MA, Vanacore N, Cotichini R, Alfò M, Pugliatti M, Sotgiu S, Solaro C, Bomprezzi R,et al. Multiple sclerosis in twins from continental Italy and Sardinia: A Nationwide Study. Ann Neurol. 2006;59:27–34.CrossRefPubMed Ristori G, Cannoni S, Stazi MA, Vanacore N, Cotichini R, Alfò M, Pugliatti M, Sotgiu S, Solaro C, Bomprezzi R,et al. Multiple sclerosis in twins from continental Italy and Sardinia: A Nationwide Study. Ann Neurol. 2006;59:27–34.CrossRefPubMed
28.
go back to reference Kuusisto H, Kaprio J, Kinnunen E, Luukkaala T, Koskenvuo M, Elovaara I. Concordance and heritability of multiple sclerosis in Finland: Study on a nationwide series of twins. Eur J Neurol. 2008;15:1106–10.CrossRefPubMed Kuusisto H, Kaprio J, Kinnunen E, Luukkaala T, Koskenvuo M, Elovaara I. Concordance and heritability of multiple sclerosis in Finland: Study on a nationwide series of twins. Eur J Neurol. 2008;15:1106–10.CrossRefPubMed
29.
go back to reference Fagnani C, Neale MC, Nisticò L, et al. Twin studies in multiple sclerosis: A meta-estimation of heritability and environmentality. Mult Scler. 2015;21(11):1404–13.CrossRefPubMed Fagnani C, Neale MC, Nisticò L, et al. Twin studies in multiple sclerosis: A meta-estimation of heritability and environmentality. Mult Scler. 2015;21(11):1404–13.CrossRefPubMed
30.
go back to reference Freeman JB, Dale R. Assessing bimodality to detect the presence of a dual cognitive process. Behav Res. 2013;45:83–97.CrossRef Freeman JB, Dale R. Assessing bimodality to detect the presence of a dual cognitive process. Behav Res. 2013;45:83–97.CrossRef
32.
go back to reference Hernán MA, Olek MJ, Ascherio A. Geographic variation of MS incidence in two prospective studies of US women. Neurology. 1999;53:1711–8.CrossRefPubMed Hernán MA, Olek MJ, Ascherio A. Geographic variation of MS incidence in two prospective studies of US women. Neurology. 1999;53:1711–8.CrossRefPubMed
33.
go back to reference Koch-Henriksen N. The Danish Multiple Sclerosis Registry: a 50-year follow-up. Mult Scler. 1999;5:293–6.CrossRefPubMed Koch-Henriksen N. The Danish Multiple Sclerosis Registry: a 50-year follow-up. Mult Scler. 1999;5:293–6.CrossRefPubMed
34.
go back to reference Freedman DM, Dosemeci M, Alavanja MC. Mortality from multiple sclerosis and exposure to residential and occupational solar radiation: A case control study based on death certificates. Occup Environ Med. 2000;57:418–21.CrossRefPubMedPubMedCentral Freedman DM, Dosemeci M, Alavanja MC. Mortality from multiple sclerosis and exposure to residential and occupational solar radiation: A case control study based on death certificates. Occup Environ Med. 2000;57:418–21.CrossRefPubMedPubMedCentral
35.
go back to reference Celius EG, Vandvik B. Multiple sclerosis in Oslo, Norway: prevalence on 1 January 1995 and incidence over a 25-year period. Eur J Neurol. 2001;8:463–9.CrossRefPubMed Celius EG, Vandvik B. Multiple sclerosis in Oslo, Norway: prevalence on 1 January 1995 and incidence over a 25-year period. Eur J Neurol. 2001;8:463–9.CrossRefPubMed
36.
go back to reference Barnett MH, William DB, Day S, Macaskill P, McLeod JG. Progressive increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: a 35-year study. J Neurol Sci. 2003;213:1–6.CrossRefPubMed Barnett MH, William DB, Day S, Macaskill P, McLeod JG. Progressive increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: a 35-year study. J Neurol Sci. 2003;213:1–6.CrossRefPubMed
37.
go back to reference Sundström P, Nyström L, Forsgren L. Incidence (1988–97) and prevalence (1997) of multiple sclerosis in Västerbotten County in northern Sweden. J Neurol Neurosurg Psychiatry. 2003;74:29–32.CrossRefPubMedPubMedCentral Sundström P, Nyström L, Forsgren L. Incidence (1988–97) and prevalence (1997) of multiple sclerosis in Västerbotten County in northern Sweden. J Neurol Neurosurg Psychiatry. 2003;74:29–32.CrossRefPubMedPubMedCentral
38.
go back to reference Ranzato F, Perini P, Tzintzeva E, Tiberio M, Calabrese M, Emani M, Davetag F, De Zanche L, Garbin E, Verdelli F, et al. Increasing frequency of multiple sclerosis in Padova, Italy: a 30 year epidemiological survey. Mult Scler. 2003;9:387–92.CrossRefPubMed Ranzato F, Perini P, Tzintzeva E, Tiberio M, Calabrese M, Emani M, Davetag F, De Zanche L, Garbin E, Verdelli F, et al. Increasing frequency of multiple sclerosis in Padova, Italy: a 30 year epidemiological survey. Mult Scler. 2003;9:387–92.CrossRefPubMed
39.
go back to reference Sarasoja T, Wikström J, Paltamaa J, Hakama M, Sumelahti ML. Occurrence of multiple sclerosis in central Finland: a regional and temporal comparison during 30 years. Acta Neurol Scand. 2004;110:331–6.CrossRefPubMed Sarasoja T, Wikström J, Paltamaa J, Hakama M, Sumelahti ML. Occurrence of multiple sclerosis in central Finland: a regional and temporal comparison during 30 years. Acta Neurol Scand. 2004;110:331–6.CrossRefPubMed
40.
go back to reference Orton SM, Herrera BM, Yee IM, Valdar W, Dyment DA, Ramagopalan SV, Sadovnick AD, Ebers GC, and the Canadian Collaborative Study Group. Sex ratio of multiple sclerosis in Canada: A longitudinal study. Lancet Neurol. 2006;5:932–6.CrossRefPubMed Orton SM, Herrera BM, Yee IM, Valdar W, Dyment DA, Ramagopalan SV, Sadovnick AD, Ebers GC, and the Canadian Collaborative Study Group. Sex ratio of multiple sclerosis in Canada: A longitudinal study. Lancet Neurol. 2006;5:932–6.CrossRefPubMed
41.
go back to reference Goodin DS, Khankhanian P. Single Nucleotide Polymorphism (SNP)-Strings: An Alternative Method for Assessing Genetic Associations. PLoS One. 2014;9(4), e90034.CrossRefPubMedPubMedCentral Goodin DS, Khankhanian P. Single Nucleotide Polymorphism (SNP)-Strings: An Alternative Method for Assessing Genetic Associations. PLoS One. 2014;9(4), e90034.CrossRefPubMedPubMedCentral
42.
go back to reference Khankhanian P, Gourraud PA, Lizee A, Goodin DS. Haplotype-based approach to known MS-associated regions increases the amount of explained risk. J Med Genet. 2015;52(9):587–94.CrossRefPubMedPubMedCentral Khankhanian P, Gourraud PA, Lizee A, Goodin DS. Haplotype-based approach to known MS-associated regions increases the amount of explained risk. J Med Genet. 2015;52(9):587–94.CrossRefPubMedPubMedCentral
Metadata
Title
The nature of genetic susceptibility to multiple sclerosis: constraining the possibilities
Author
Douglas S. Goodin
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2016
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-016-0575-6

Other articles of this Issue 1/2016

BMC Neurology 1/2016 Go to the issue